Skip to content
HowShorted

OPKO Health, Inc. short interest in 2018

In 2018, OPKO Health, Inc.'s disclosed short interest ran from 10.08% of shares outstanding on 12 Jan 2018 to 10.04% on 31 Dec 2018, a change of -0.04 percentage points. The year's high was 13.81% on 31 Jul 2018 and its low 9.66% on 31 Jan 2018, averaging 12.00% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 23.83 days on 31 Aug 2018. Full history: OPKO Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for OPKO Health, Inc. in 2018

2018 in figures

Start of year
10.08% (12 Jan 2018)
End of year
10.04% (31 Dec 2018)
Change
-0.04 pp
High
13.81% (31 Jul 2018)
Low
9.66% (31 Jan 2018)
Average
12.00%
Highest days to cover
23.83 (31 Aug 2018)
SEC filings marked
10

Every report in 2018

OPKO Health, Inc. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 201810.08%19.44
31 Jan 20189.66%9.15
15 Feb 201810.28%10.97
28 Feb 201811.69%14.37
15 Mar 201811.16%11.0010-K filed, results (8-K), results (8-K)
29 Mar 201811.62%12.54
13 Apr 201811.92%16.34
30 Apr 201811.81%20.23
15 May 201812.04%11.1810-Q filed, results (8-K)
31 May 201812.38%10.38
15 Jun 201813.21%15.48
29 Jun 201813.08%9.31
13 Jul 201813.11%10.72
31 Jul 201813.81%9.85
15 Aug 201813.72%13.8310-Q filed, results (8-K), results (8-K)
31 Aug 201813.59%23.83
14 Sep 201813.23%11.71
28 Sep 201812.97%9.42
15 Oct 201811.91%14.56
31 Oct 201811.87%17.84
15 Nov 201811.76%12.9010-Q filed, results (8-K)
30 Nov 201811.85%20.84
14 Dec 201811.13%14.80
31 Dec 201810.04%6.78

See also: OPKO Health, Inc.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.